FDA grants priority review for Enspryng in thyroid eye disease

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A BMO upgrades Replimune stock rating on FDA filing progress Hisse Senetleri 0 1
A Palisade Bio receives FDA clearance for ulcerative colitis trial Hisse Senetleri 0 2
A Lantheus stock holds at Market Outperform despite FDA setback Hisse Senetleri 0 2
A FDA issues complete response letter for Lantheus’ NET imaging drug Hisse Senetleri 0 5
A FDA proposes registration rule for foreign tobacco makers Hisse Senetleri 0 3
A FDA grants priority review for Eisai’s Alzheimer’s treatment autoinjector Hisse Senetleri 0 31
A FDA grants Clene in-person meeting to discuss ALS drug biomarker data Hisse Senetleri 0 36
A Atossa Therapeutics stock soars after FDA grants rare pediatric disease status Hisse Senetleri 0 35

Benzer konular

Üst